Table 2.
Results of the meta-analysis of GWAS of asthma in Puerto Ricans, for SNPs associated with asthma in two previous meta-analysis in Europeans (by the GABRIEL consortium) and ethnically diverse North Americans (by the EVE consortium)
| SNP | Chr | Position | Ref | Alt | Gene | In cited paper | Hartford-PR | GALA I | GALA II | HCHS/SOL | Combined | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
||||||||||||||
| OR | AAF | OR | P-value | AAF | OR | P-value | AAF | OR | P-value | AAF | OR | P-value | OR | P-value | ||||||
| Loci reported by the GABRIEL consortium in Moffatt M.F. et al. N Engl J Med 2010; 363:1211–21 | ||||||||||||||||||||
| rs3771166 | 2 | 102986222 | G | A | IL18R1 | 0.85* | 0.45 | 0.90 | 0.500 | 0.44 | 0.75 | 0.114 | 0.43 | 0.85 | 0.018 | 0.46 | 1.14 | 0.110 | 0.94 | 0.111 |
| rs9273349 | 6 | 32625869 | A | G | HLA-DQ | 1.14 | 0.61 | 0.98 | 0.860 | NA | NA | NA | NA | NA | NA | 0.62 | 1.22 | 0.016 | 1.13 | 0.079 |
| rs1342326 | 9 | 6190076 | A | C | IL33 | 1.27 | 0.21 | 0.90 | 0.403 | 0.26 | 1.12 | 0.571 | 0.22 | 1.05 | 0.528 | 0.20 | 1.13 | 0.213 | 1.05 | 0.376 |
| rs744910 | 15 | 67446785 | G | A | SMAD3 | 0.89 | 0.43 | 0.88 | 0.175 | 0.42 | 1.01 | 0.981 | 0.45 | 0.93 | 0.269 | 0.45 | 1.05 | 0.572 | 0.95 | 0.326 |
| rs2305480 | 17 | 38062196 | G | A | GSDMB | 0.76 | 0.31 | 0.62 | 2.0×10−6 | 0.31 | 0.54 | 0.003 | 0.32 | 0.71 | 6.7×10−6 | 0.34 | 0.86 | 0.071 | 0.72 | 7.4×10−12 |
| rs3894194 | 17 | 38121993 | G | A | GSDMA | 1.26 | 0.37 | 1.23 | 0.034 | 0.39 | 0.92 | 0.648 | 0.40 | 1.23 | 0.002 | 0.39 | 0.94 | 0.406 | 1.11 | 0.023 |
| rs2284033 | 22 | 37534034 | G | A | IL2RB | 0.92 | 0.41 | 0.91 | 0.272 | 0.39 | 1.09 | 0.638 | 0.40 | 1.17 | 0.024 | 0.42 | 1.00 | 0.997 | 1.04 | 0.289 |
| rs2073643 | 5 | 131723288 | T | C | SLC22A5 | 0.89 | 0.50 | 0.96 | 0.668 | 0.48 | 1.18 | 0.356 | 0.50 | 0.93 | 0.257 | 0.51 | 1.01 | 0.856 | 0.98 | 0.551 |
| rs1295686 | 5 | 131995843 | T | C | IL13 | 0.85 | 0.59 | 1.01 | 0.943 | 0.62 | 0.75 | 0.136 | 0.62 | 0.90 | 0.159 | 0.61 | 1.07 | 0.398 | 0.96 | 0.408 |
| rs11071559 | 15 | 61069988 | C | T | RORA | 0.88 | 0.26 | 1.07 | 0.525 | 0.25 | 1.69 | 0.012 | 0.24 | 0.90 | 0.193 | 0.24 | 0.85 | 0.087 | 0.96 | 0.486 |
| Replicated genes reported by the EVE consortium in Torgerson D.G. et al. Nat. Genet. 2011; 43(9):887–92 | ||||||||||||||||||||
| rs1102000 | 1 | 158932907 | T | C | PYHIN1 | 0.76# | 0.08 | 1.09 | 0.651 | 0.06 | 0.50 | 0.061 | NA | NA | NA | 0.07 | 1.21 | 0.986 | 0.93 | 0.611 |
| rs10173081 | 2 | 102957348 | C | T | IL1RL1 | 0.83 | 0.19 | 0.84 | 0.132 | 0.16 | 0.85 | 0.519 | 0.26 | 0.78 | 0.010 | 0.18 | 0.93 | 0.506 | 0.84 | 0.004 |
| rs1837253 | 5 | 110401872 | C | T | TSLP | 0.84 | 0.25 | 0.73 | 0.004 | 0.23 | 0.65 | 0.041 | 0.27 | 0.83 | 0.014 | 0.26 | 0.96 | 0.701 | 0.82 | 2.5×10−4 |
| rs2381416 | 9 | 6193455 | A | C | IL33 | 1.18 | 0.38 | 0.98 | 0.847 | 0.39 | 1.00 | 0.980 | 0.37 | 1.09 | 0.249 | 0.35 | 1.13 | 0.157 | 1.07 | 0.155 |
| rs11078927 | 17 | 38064405 | C | T | GSDMB | 0.79 | 0.30 | 0.61 | 1.4×10−6 | 0.31 | 0.55 | 0.003 | 0.31 | 0.71 | 7.9×10−6 | 0.34 | 0.86 | 0.079 | 0.72 | 8.1×10−12 |
Ref: reference allele; Alt: alternative allele; AAF: alternative allele frequency; OR: odds ratio.
This column is childhood onset odds ratio in Moffatt M.F. et al. N Engl J Med 2010; 363:1211–21;
This column is overall odds ratio in Torgerson D.G. et al. Nat. Genet. 2011; 43(9):887–92.
Human Genome version: hg19